Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 18, 2019 9:00 am

Filmmakers Poised for Big Gains in Hollywood’s ‘Streaming Wars’

NetworkNewsWire Editorial Coverage: While big streaming companies battle it out for supremacy, the real winners of an epic battled dubbed the “streaming wars” may have already emerged: the production companies that stand to profit in a big way from the exploding demand for SVoD content. As digital streaming steadily eclipses all other forms of in-home entertainment delivery, an entertainment war has erupted among leading subscription video on demand (SVoD) providers. These streaming wars have opened the gate for newer production companies to step up and cash in by funneling fresh content to hungry SVoDs. The battle has already resulted in…

Continue Reading

TuesdayDec 03, 2019 9:00 am

Unleashing the Disruptive Forces of 3D Printing

NetworkNewsWire Editorial Coverage: 3D-printing technology has arrived and appears ready to beneficially disrupt every field it touches. Additive manufacturing, better known as three-dimensional or 3D printing, has potential to change the world. However, the full promise of the technology has been stymied due to the high costs and complexities of end-product inspection and quality control. With its pioneering PrintRite3D(R) software, Sigma Labs Inc. (NASDAQ: SGLB) (SGLB Profile) appears to be ready to help unleash the transformative forces of 3D printing and usher in what’s been called the fourth industrial revolution. Aerospace has embraced 3D printing and, for the first time…

Continue Reading

TuesdayNov 19, 2019 9:00 am

Profiting from the Fourth Industrial Revolution

NetworkNewsWire Editorial Coverage: Heralded as the fourth industrial revolution, 3D printing is about to transform the $12 trillion global manufacturing sector. Sigma Labs Inc. (NASDAQ: SGLB) (SGLB Profile) is on the verge of unleashing the dynamic forces of additive metal manufacturing that have been restrained. Long heralded as the fourth industrial revolution, 3D metal printing and its full potential have been stalled due to the high cost and complexities of end-product inspection and quality control. Sigma Labs’ PrintRite3D(R) software represents a seismic shift in the quality-assurance process in the manufacture of 3D-printed metal components, and the entire sector is poised…

Continue Reading

TuesdayNov 05, 2019 9:00 am

Entertainment Businesses Adopt New Approaches for Streaming Age

NetworkNewsWire Editorial Coverage: As video streaming grows to dominate media consumption, companies are on the lookout for new ways to profit from the burgeoning trend. Wonderfilm Media Corporation (TSXV: WNDR) (OTCQB: WDRFF) (WDRFF Profile) has developed a low-risk approach to content production by providing original works with top Hollywood talent. Apple Inc. (NASDAQ: AAPL) is launching its new TV+ service with a slew of big-name stars and big-budget productions. Netflix Inc. (NASDAQ: NFLX) continues to be a dominant player, with a strong mix of original and established content. The Walt Disney Company (NYSE: DIS) is using its range of high-profile…

Continue Reading

TuesdayNov 05, 2019 9:00 am

New Hope in the Battle Against Ovarian Cancer

NetworkNewsWire Editorial Coverage: Despite the enormous progress made in the war against cancers, ovarian cancer has proved to be a tenacious foe. Progress is being made, however, as AI predictive models are being used to better target deadly ovarian cancers. Ovarian cancer is difficult to treat and lethal, with survival rates much lower than other cancers that affect women. Recently, the battle against ovarian cancer has shifted strategy, and new optimism has come to the fore. Predictive models using artificial intelligence on large data sets of patient drug-treatment protocols and historical outcomes are now providing actionable intelligence for pharma to…

Continue Reading

TuesdayOct 29, 2019 9:00 am

Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics

NetworkNewsWire Editorial Coverage: The field of precision medicine has latched upon what may well be the Holy Grail in the fight against cancer. When big data are utilized by teams of pathologists, data can be incredibly helpful, but when the right data are comprehensively analyzed by artificial intelligence (AI)-powered models, the data can be downright lifesaving. Predictive Oncology (NASDAQ: POAI) (POAI Profile) is in an enviable position in the precision-medicine industry due to its incredibly rich data set of more than 150,000 clinically validated cases on its molecular information platform, with 30,000-plus specific to ovarian cancer. The company is leveraging…

Continue Reading

TuesdaySep 24, 2019 9:00 am

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers

NetworkNewsWire Editorial Coverage: Advances in biotechnology look to deliver promising new treatment options against breast cancer. Independent researchers have found that Genprex Inc.’s (NASDAQ: GNPX) (GNPX Profile) TUSC2 prevented tumor growth against triple-negative breast cancer. Eli Lilly and Company (NYSE: LLY) is focusing on those patients with the greatest need and, in the process, has developed a new breast-cancer treatment option. Roche Holding (OTCQX: RHHBY) is expanding the use of its biotech to both identify and treat patients with challenging breast cancers. AbbVie Inc. (NYSE: ABBV) has been rapidly increasing its research, targeting more than 15 different types of cancer.…

Continue Reading

WednesdaySep 04, 2019 9:00 am

Innovative Drug-Delivery Systems Benefit Patients and Businesses

NetworkNewsWire Editorial Coverage: Drugs play an essential role in treating anything from a mild headache to life-threatening disease — and everything in between. While effectiveness of drugs is what most often captures the spotlight, that effectiveness is closely associated with the drug-delivery technology used, and innovation in this space may have a huge impact on how successful a drug can be. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed one of the most innovative drug-delivery systems seen in years, a system that can be used to deliver a wide range of drugs in a more palatable and…

Continue Reading

WednesdaySep 04, 2019 9:00 am

Gene Therapy Treatments Offer Hope for Cancer Patients

NetworkNewsWire Editorial Coverage: Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different…

Continue Reading

WednesdayAug 21, 2019 9:00 am

Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector

NetworkNewsWire Editorial Coverage: Biotech and biopharma industry leaders are posting record financials and hitting milestone markers in their research and growth, good indicators of a strong market with potential for robust returns on investment. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) has completed key steps in its overall strategy to expand its clinical development programs and bring Oncoprex(TM) immunogene therapy, its lead drug candidate, to commercialization. Over the past five years, Amgen Inc. (NASDAQ: AMGN) has invested nearly $19 billion in R&D and, as a result, is now advancing a record number of clinical assets. Biogen Inc. (NASDAQ: BIIB) has added four new programs…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000